These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10763108)

  • 1. [The action of a new taurine derivative in different variants of hypoxic states].
    Torkunov PA; Sapronov NS
    Eksp Klin Farmakol; 2000; 63(1):37-40. PubMed ID: 10763108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of a new phenylalkyl taurine derivative on the size of the necrotic area in experimental myocardial infarct in rats].
    Sapronov NS; Torkunov PA; Eliseev VV; Krylova IB; Evdokimova NR
    Patol Fiziol Eksp Ter; 1999; (4):19-20. PubMed ID: 10598458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurogenic heart injuries and their pharmacological correction by a new taurine derivative].
    Zafodskaia IS; Khnychenko LK; Sapronov NS
    Vestn Ross Akad Med Nauk; 2002; (12):41-4. PubMed ID: 12611176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antioxidant action of taurine in acute hypoxic hypoxia].
    Man'kovs'ka IM; Seredenko MM; Vavilova HL; Kharlamova OM; Bystriukov VO
    Fiziol Zh (1994); 1998; 44(5-6):65-72. PubMed ID: 9866027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic Activity of Taurepar during Ischemic and Reperfusion Damage to Myocardium.
    Krylova IB; Bul'on VV; Selina EN; Sapronov NS; Shabanov PD
    Bull Exp Biol Med; 2015 Dec; 160(2):228-30. PubMed ID: 26639469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of taurine antihypoxic and antioxidant action.
    Mankovskaya IN; Serebrovskaya TV; Swanson RJ; Vavilova GL; Kharlamova ON
    High Alt Med Biol; 2000; 1(2):105-10. PubMed ID: 11256561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the oxygen-binding properties of the blood in white rats under the influence of hypoxia and its pharmacological correction].
    Dudariev VP; Lanovenko II
    Fiziol Zh (1994); 1999; 45(1-2):97-103. PubMed ID: 10202642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some mechanisms of antihypoxic action of taurine].
    Mankovska IM; Nosar VI; Nazarenko AI; Govorukha TM; Bratus LV
    Fiziol Zh (1978); 1992; 38(5):81-8. PubMed ID: 1305090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-propionylcarnitine taurine amide induces the metabolic recovery of the isolated postischemic rat heart].
    Lazzarino G; Corsico N; Tavazzi B; di Pierro D; Arrigoni-Martelli E; Giardina B
    Cardiologia; 1992 Oct; 37(10):715-7. PubMed ID: 1296879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic shifts in stress caused by hunger, and pharmacotherapy of them by a new taurine derivative].
    Khnychenko LK
    Patol Fiziol Eksp Ter; 2001; (4):16-8. PubMed ID: 11871021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effects of a new taurine derivative in chronic hepatic diseases].
    Khnychenko LK; Bul'on VV; Sapronov NS; Kudriashova NI
    Patol Fiziol Eksp Ter; 2002; (1):6-8. PubMed ID: 11998405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart function and the mechanisms of its regulation in modelling adaptation to hypoxia by 2,4-dinitrophenol administration].
    Ivanov AI; Khitrov NK
    Kardiologiia; 1983 Jan; 23(1):94-8. PubMed ID: 6403746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The interrelationship of doses and the pharmacological effects of cardiac peptides].
    Pavlenko VS; Andreeva LI; Ershov VI; Khavinson VKh; Khlystov VV
    Biull Eksp Biol Med; 1992 Jul; 114(8):171-3. PubMed ID: 1467483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The protective action of nimodipine on the ischemic myocardium].
    Tsorin IB; Kazanova GV; Kirsanova GIu; Chirkova EIu; Chichkanov GG
    Eksp Klin Farmakol; 1992; 55(6):14-7. PubMed ID: 1305864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
    Paperno AA; Kovalev GV; Gurbanov KG
    Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cardiotoxic properties of kordaron in acute myocardial ischemia and infarct].
    Spasov AA; Gurova NA; Panchenko TI
    Eksp Klin Farmakol; 1998; 61(6):25-30. PubMed ID: 9929812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective effect of taurine on "hypoxic" and "reoxygenated" guinea pig heart.
    Franconi F; Stendardi I; Matucci R; Bennardini F; Baccaro C; Giotti A
    Prog Clin Biol Res; 1985; 179():177-82. PubMed ID: 4059212
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of the perfused rat heart as a model for selecting antihypoxic compounds].
    Korneev AA; Sheveleva GA
    Farmakol Toksikol; 1991; 54(3):67-70. PubMed ID: 1915831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of taurine in the treatment of experimental congestive heart failure].
    Orlova TsR; Elizarova EP; Ryff IM; Fetisova NI; Mit'kina LI
    Kardiologiia; 1991 Jun; 31(6):77-80. PubMed ID: 1921137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.